PubMed 27848933

PubMed ID: 27848933

View on PubMed
Genome editing in maize directed by CRISPR-Cas9 ribonucleoprotein complexes.
Authors: Svitashev Sergei, Schwartz Christine, Lenderts Brian, Young Joshua K, Mark Cigan A
Journal: Nature communications (Nat Commun), Vol.7(), 2016‑Nov‑16

DOI: 10.1038/ncomms13274 PMCID: PMC2690996

Abstract
Targeted DNA double-strand breaks have been shown to significantly increase the frequency and precision of genome editing. In the past two decades, several double-strand break technologies have been developed. CRISPR-Cas9 has quickly become the technology of choice for genome editing due to its simplicity, efficiency and versatility. Currently, genome editing in plants primarily relies on delivering double-strand break reagents in the form of DNA vectors. Here we report biolistic delivery of pre-assembled Cas9-gRNA ribonucleoproteins into maize embryo cells and regeneration of plants with both mutated and edited alleles. Using this method of delivery, we also demonstrate DNA- and selectable marker-free gene mutagenesis in maize and recovery of plants with mutated alleles at high frequencies. These results open new opportunities to accelerate breeding practices in a wide variety of crop species.
Publication Types
Journal Article
Related Articles